Clinical Trial Update: To Assess the Safety and Efficacy of Ciclesonide, Applied as a Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (BY9010/M1-401) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating ciclesonide nasal spray for seasonal allergic rhinitis (hay fever) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Hay Fever
• Seasonal Allergic Rhinitis

Drugs mentioned

• Ciclesonide nasal spray (ciclesonide)

Snippet

Sponsor: AstraZeneca | Conditions: Rhinitis, Allergic, Seasonal, Hay Fever | Phase 3 | Status: COMPLETED